Trial Identifier: | D7930C00005 |
Sponsor: | AstraZeneca |
Collaborator: |
Parexel
|
Start Date: | February 2025 |
Primary Completion Date: | April 2025 |
Study Completion Date: | April 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
US, MD | Brooklyn, MD, US, 21225 |